Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Buying a pharmacy is not as easy as it once was

As someone fortunate enough to have retired relatively wealthy from self-employment within community pharmacy some 20 years ago, and having made even more from investment since, I found the article written by Sean Dixon on buying a pharmacy (The Pharmaceutical Journal 2015;294:531) interesting, particularly in his breakdown of the main annual revenue available from the sector.

He describes an idealistic situation relating to most peoples’ concept of local banking within the high street today, which I no longer recognise. Bank managers who had some idea of retail business, able to understand a proposition for a loan and to make the necessary decisions seem no longer to exist in my local branch of Lloyds. Rather, the place appears nowadays to be more like an understaffed shop hard-selling pre-packed financial products by people with little training and no concept of finance.

No matter, with the present resale value of any pharmacy with an attractive turnover, the stake needed, even to justify a loan to buy the same, is going to be beyond the reach of most pharmacists.

I was on the Council of the old Royal Pharmaceutical Society during the mid-1980s when David Sharpe, a member of Council and chairman of the Pharmaceutical Services Negotiating Committee, first muted the concept of negotiating some form of limitation of entry into pharmacy contract at a time when there was no security in the retail sector due to “leapfrogging” (opening a pharmacy closer to a doctor’s surgery than the nearest pharmacy). This limitation came to be, with the “desirable and necessary” criteria being introduced — which exist to this day — and the barriers to entry which Dixon described were born. Little did any of us realise at the time just how much this provision would elevate the goodwill being asked for businesses at the point of sale.

Mike Brunt

Thetford,

Norfolk

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068543

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.